Products for Research Use Only
RegisterLogin

Naxitamab

CAT: 0804-HY-P99206-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99206-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers[1].
CAS Number
1879925-92-4
Product Name Alternative
Naxitamab-gqgk; Humanized 3F8; Hu3F8
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/naxitamab.html
Purity
99.84
Solubility
10 mM in DMSO
Smiles
[Naxitamab]
Molecular Weight
(144.38 kDa)
References & Citations
[1]Cheung NK, et, al. Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo. Oncoimmunology. 2012 Jul 1;1 (4) :477-486.|[2]Markham A. Naxitamab: First Approval. Drugs. 2021 Feb;81 (2) :291-296.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 4

Alternative Products

CatalogName
E40YR1539Naxitamab
GTR18333593-01Naxitamab Antibody
592038Naxitamab (Ganglioside GD2)
WA3213Research Grade Naxitamab
A2486-1mg*5Naxitamab (Anti-GD2)
048014GD2 (naxitamab) discontinued
KBI1494KRIBIOLISA™ Naxitamab ELISA
E55B0756Naxitamab (Reference antibody)
F1501-.1Anti-GD2 Antibody (Naxitamab)
PX-TA2534-01Naxitamab Biosimilar - Research Grade

Popular Products